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ABSTRACT 
HUMAN PAPILLOMAVIRUS VACCINE PROGRAM 
Pediatric primary care focuses on maintaining patients’ health, preventing 
diseases, and assessing children’s developmental milestones.  Vaccine 
administration and disease prevention are key components of a well-child exam 
for pediatric patients; however, vaccine refusal is an important complication of 
pediatric patient care.  Of particular interest to this researcher is the HPV vaccine 
which was approved by the Federal Drug Administration and is currently 
recommended by the Centers for Disease Control and Prevention (2016) for both 
males and females, beginning at 11 or 12 years of age through age 26 years.  The 
HPV vaccine protects against diseases and cancers caused by the HPV virus; thus, 
it is important that primary caregivers of pediatric patients be informed about the 
benefits of this vaccine to ensure that more caregivers give their consent to 
administer the vaccine.  This Doctor of Nursing Practice (DNP) project was 
designed to evaluate parental refusal for the human papillomavirus (HPV) vaccine 
via in-person interviews, vaccine teaching sessions, and a subsequent evaluation of 
the effect of these sessions on parental consent to the HPV vaccine.  This project 
took place in a rural pediatric health clinic, and a total of 12 parents completed the 
one-month follow-up phone assessments. The results of this study noted a positive 
impact of the vaccine teaching sessions on the parental decision to consent to the 
HPV vaccine in the clinic, revealing that seven parents (58%) changed their 
decision from refusing the HPV vaccine to consenting to its administration.  
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CHAPTER 1: INTRODUCTION 
Introduction 
As a nurse practitioner working in a rural healthcare setting, the author of 
this study understands that preventative healthcare is a priority in medical practice.  
The focus of preventative healthcare is to prevent disease, and one way to 
accomplish this is to administer vaccines recommended by the Centers for Disease 
Control and Prevention (CDC).  As advised and scheduled by the CDC and 
approved by the American Academy of Pediatrics (AAP) (2013), vaccines have 
been shown to protect against life threatening illnesses (CDC, 2016).  This study 
focused on the human papillomavirus vaccine (HPV) which prevents infection 
from strains that are associated with many cancers, including throat, cervical, oral, 
and penile (CDC, 2016).  The HPV vaccine is recommended at age nine years for 
both female and male pediatric patients.  The goal of this project for the Doctor of 
Nursing Practice, (DNP) was to create an HPV program which determined the 
reasons for parental refusal and implemented a vaccine education program for 
parental providers which could increase vaccine compliance and vaccine 
completion series rates.  
Background 
Immunization is the process whereby a person is made immune or resistant 
to an infectious disease, typically by the administration of a vaccine (World Health 
Organization [WHO], 2015). The Food and Drug Administration has approved 
three vaccines that prevent infection due to HPV strains: Gardasil, Gardasil 9, and 
Cervarix (National Cancer Institute [NCI], 2018).  HPV is a very common virus 
with nearly 80 million people—about one in four—currently infected in the 
United States (CDC, 2016).  About 14 million people, including teens, become 
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infected with HPV each year (CDC, 2016).  Risks of the HPV virus vary, but the 
most serious conditions include oral cancer, genital cancer, genital warts, and 
cervical cancer (CDC, 2016).  According to research conducted by the CDC, 
adolescents in rural areas obtain the HPV vaccine less often than those who live in 
urban areas (CDC, 2018).  The vaccine is routinely given at 11 or 12 years of age, 
but it may be given as early as age nine and as late as age 26 (CDC, 2016).  
Vaccine completion is as follows: adolescents 9 through 14 years of age receive 
the HPV vaccine as a two-dose series with the doses separated by 6 - 12 months; 
individuals who begin HPV vaccination at 15 and older should get the vaccine as a 
three-dose series with the second dose given 1 - 2 months after the first dose and 
the third dose given 6 months after the first dose (CDC, 2016).  Parental refusal to 
allow the administration of the HPV vaccine has been identified as a common 
obstacle in vaccine compliance and health promotion in adolescent patients who 
live in rural areas.  According to the National Cancer Institute at the National 
Institute of Health, the combination of HPV vaccination and cervical screening 
can provide the greatest protection against cervical cancer (NCI, 2018).  The 
primary goal of this vaccine program research project was to encourage 
caregivers/parents to consent to the administration of the HPV vaccine to their 
children by providing the former with information that focused on the importance 
of HPV disease prevention and vaccine education.  The implementation of vaccine 
education programs such as this in other healthcare settings may lead to positive 
changes that will increase HPV vaccine compliance and decrease parental vaccine 
refusal. 
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Problem Statement 
Vaccine compliance and parental refusal have become issues that advanced 
practice nurses need to address.  Despite the importance of vaccines in preventing 
communicable diseases, there has been a large increase in vaccine refusal in the 
21st century (WHO, 2015).  Globally, one in five children still does not receive 
routine life-saving immunizations, and an estimated 1.5 million children still die 
each year of diseases that could have been prevented by vaccines that are already 
in existence (WHO, 2015).  In primary care settings, such as rural healthcare 
clinics where pediatric patient care is provided, there has been an increase in 
parental refusal to vaccines, including the HPV vaccine.  According to a survey 
conducted by the Academy of Pediatrics in 2009, 11.5% of parents with children 
17 years and younger reported refusing at least one vaccine (American Academy 
of Pediatrics [AAP], 2013).  Through the evaluation of parental vaccine 
knowledge, promoting provider/parent communication, and implementing a 
vaccine program, this study identified barriers to vaccine compliance. 
Purpose of the Project  
The purpose of this HPV vaccine program was to identify and address 
barriers for vaccine refusal for adolescent patients in the rural healthcare clinic 
setting.  Additional goals of this program were to evaluate the impact of a vaccine 
education program on vaccine compliance, increase vaccine rates in a rural health 
care clinic, and determine whether or not provider/parental dialogue could 
improve the likelihood of parents agreeing to the HPV vaccine series. 
The emphasis of public healthcare is to address barriers affecting a specific 
patient population.  In caring for pediatric patients in the rural healthcare setting, it 
is important to acknowledge parents’ behavior toward their children’s healthcare 
interventions, including immunizations.  In providing patient care, advanced 
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practice nurses can use various nursing theories to help impact patient care and 
health outcomes. 
Theoretical Framework and Application to Practice 
The health belief model (HBM) is the nursing theory that may be applied to 
the vaccine non-compliance issue and vaccine parental refusal in the pediatric 
primary care setting.  The HBM is a theory that focuses on health behavior which 
was originally developed in the 1950s to predict whether individuals would be 
willing to engage in programs aimed at preventing and detecting disease (Gerend 
& Shepard, 2012).  The HBM was first developed by social psychologists working 
in public health services within the U.S.  The social psychologists who developed 
the model looked at ways to explain why so few people were participating in 
programs aimed at preventing and detecting disease (Butts & Rich, 2018).  During 
the 1950s, HBM was used to evaluate the polio vaccine and its risks for public 
health.  The factors identified soon became the basis for the HBM and have been 
used throughout the public healthcare field to explain why people adopt behaviors 
that lead to better health (Smith, et al., 2011).  Researchers included six main 
constructs pertaining to the model: perceived susceptibility, perceived severity, 
perceived benefits, perceived barriers, cue to action, and self-efficacy (Butts & 
Rich, 2018).  Focusing on the identified six constructs regarding parents’ views on 
disease prevention may guide vaccine programs to work toward increasing vaccine 
compliance and preventing or decreasing parental vaccine refusal.  
To conduct the HPV vaccine program, this researcher addressed the above-
mentioned HBM constructs in the following manner: 
1. Perceived susceptibility of HPV infection: educate parents on HPV risk 
and infection. 
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2. Perceived severity of disease: explain HPV risks in causing cervical 
cancer. 
3. Perceived benefits: explain that decreasing the risk of HPV may 
decrease the risk of diseases, including oral and cervical cancer. 
4. Perceived barriers: explain that complying with scheduled vaccine doses 
may prevent HPV infection. 
5. Cue to action: provide advanced practice nurse recommendation and a 
parent/provider education time. 
6. Self-efficacy: obtain parental permission to administer vaccine to 
adolescent patient.  
This vaccine program used these six constructs of the HBM as a guide in 
acknowledging parental feelings toward vaccines and to work toward increasing 
the vaccine compliance rate.  Focusing the HBM in this research study not only 
helped this researcher identify strategies to change health behaviors regarding 
vaccine compliance, but it may also continue to guide advance practice nurses to 
implement changes that may benefit their pediatric patients.  
Summary 
A key element to advanced practice nurses is focusing on preventative 
health measures while providing primary care to patients.  When caring for 
pediatric patients, it is important to acknowledge parental concerns and health 
beliefs while creating parental/provider rapport which may improve patient 
healthcare outcomes.  The following HPV vaccine program may assist health care 
providers, such as nurse practitioners, in determining factors associated with 
parental vaccine refusal.  Identifying these barriers to vaccine compliance may 
then guide interventions needed for increasing vaccine compliance rates in 
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pediatric rural healthcare clinics.  The following chapter reviews the literature 
which examined the reasons for parental HPV vaccine refusal. 
   
CHAPTER 2: LITERATURE REVIEW 
During the research aspect of this HPV vaccine program, the literature was 
reviewed regarding parental concerns about administering the HPV vaccine to 
their children.  The primary database used for this research was California State 
University, Fresno’s online library search engine, including search websites such 
as Science Direct. Most of the research suggested that education and 
misconceptions are among the leading reasons for refusal of the HPV vaccine 
(Kinder, 2016).  This literature review examines various studies which identified 
reasons for parental refusal of the HPV vaccine and also examines the gaps in 
research which were identified in the vaccine program conducted by this 
researcher. 
Parental Refusal of the HPV Vaccine 
Primary Caregiver Views on HPV 
Vaccine.  
Kinder (2016) examined and evaluated parental refusal of the Gardasil Vaccine 
in a pediatric clinic.  This study used a mixed-methods approach using parental 
surveys that were conducted after visits in which parents had deferred the Gardasil 
Vaccine. Kinder (2016) collected 23 surveys.  A descriptive statistics approach 
was used to analyze the data collected in survey answers.  The results in answers 
varied, but most parents (75%) deferred administration of the HPV vaccine 
because they believed it was too new or required further research (Kinder, 2016).  
One limitation to this study was the sample size; this study was a pilot study, but it 
seemed to confirm and share findings with other studies concerning the vaccine 
(Kinder, 2016).  A strength to this study included the determination of 
implications for nurse practitioners: recommendations of necessary changes to and 
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new strategies in the approach nurse practitioners use in offering the Gardasil 
vaccine (Kinder, 2016). 
Medical Provider Views on Vaccine 
Refusal. 
Fleming, Sznajder, Nepps, and Boktor (2018) utilized a different approach 
and researched the healthcare providers’ points of view toward Gardasil vaccine 
education programs as well as their views on barriers to the administration of the 
Gardasil vaccine.  This study took place in Pennsylvania and surveyed providers 
who practiced within the federally funded Vaccines for Children (VFC) program.  
The design of this research was cross-sectional; data were gathered using emailed 
surveys which contained 18 questions that were obtained from the validated PA 
VFC program’s “Annual Program Satisfaction Survey” (Fleming, Sznajder, 
Nepps, & Boktor, 2018, p. 449).  The survey used three types of questions: closed-
ended, Likert-scale, and open-ended.  Descriptive studies were used to analyze the 
data.  After contacting 1478 providers via email surveys, a total of 772 surveys 
were completed.  In the study, the healthcare providers’ facilitators and barriers to 
human papillomavirus (HPV) vaccination were evaluated (Fleming et al., 2018). 
The survey results concluded that the most important factor identified by providers 
was counseling parents and adolescents on the benefits of HPV vaccination, 
(79.5%).  The findings of this study indicated that the providers identified that 
parental concerns about the HPV vaccine and sexual behavior are barriers to the 
HPV vaccine (Fleming et al., 2018).  This study also revealed that providers 
preferred web-based training regarding vaccine education.  The strengths of this 
research included the identification of vaccine education programs for 
pediatricians, an emphasis on pediatrician views on parental vaccine refusal.  The 
latter may guide pediatric practice vaccine programs for providers and parents.  
 9 9 
Furthermore, a final strength of this study was its large sample size.  The 
limitations of this study pertained to respondents and the lack of a pilot survey: not 
all respondents were pediatricians, and a pilot survey was not conducted prior to 
using the survey during research study; this could have potentially created an issue 
during data collection (Fleming et al., 2018). 
Pediatrician Point of View on 
Vaccine Refusal.  
Leib, Liberatos, & Edward (2011) conducted a quantitative study, in which 
surveys were sent to 600 pediatricians. The pediatricians were chosen randomly 
via a computer during November and December 2007, and surveys were returned 
by February 2008 (p. 14).  The sample consisted of a total of 133 pediatricians (a 
31% response rate) who filled out a 28-item survey via mail.  The study took place 
in pediatric clinics in Connecticut.  The pediatricians who participated in surveys 
were all members the Hezekiah Beardsley Connecticut Chapter of the AAP and 
received consent from the organization to participate (p. 14).  The pediatricians 
were asked questions focusing on providers’ experiences with family vaccine 
refusal, identifying the vaccines being refused, and whether physicians dismissed 
these families from their practice.  The data analysis was conducted using a chi-
square analysis.  The results showed that nearly three-quarters of the pediatricians 
reported “an increase in parental concerns and refusals compared with 10 years 
ago” (Leib, Libratos, & Edward 2011, p.16).  One strength of the study was its 
focus on the pediatricians’ point of view rather than just parental thoughts on the 
Gardasil vaccine.  The low response rate of 31%, is a limitation to the study.  It 
would be helpful to obtain a larger response rate to help identify further patterns 
leading to parental vaccine refusal. (Leib et al., 2011).  
 10 10 
Javaid et al. (2017) conducted a study on the barriers to the Gardasil 
vaccine.  The researchers sent surveys via email to medical facilities in the state of 
Texas.  There was a total of 1132 responses that were received, representing 
healthcare providers, administration, and other managerial staff.  A descriptive 
statistics analysis was conducted using the survey software, Qualtrics.  Javaid et 
al. (2017) found that parental perceptions about HPV, parental knowledge, and 
safety concerns were barriers affecting Gardasil vaccine rates (Javaid et al., 2017).  
Providers stated that vaccine refusal was primarily related to misconceptions about 
the HPV disease, the safety of the vaccine, and society’s views about why the 
vaccine should be administered.  The nursing implications of this study are that 
such misconceptions should be addressed when providing patient care, and parents 
should be educated about the vaccine’s purpose; this may help increase 
vaccination rates and decrease vaccine refusal.  A limitation of this study would be 
the mode of survey distribution via email.  Methods such as in-person interviews 
and follow-up surveys may increase survey distribution and response rate.  In this 
study, the respondents varied in profession and medical background; focusing on 
primary care providers such as physicians, nurse practitioners, and physician 
assistants may provide a better evaluation of parental barriers to vaccine 
administration.  Parents often consider the medical advice given to them by their 
primary care provider the best for their children’s health decisions. Parents may 
rely on the primary care providers’ medical advice to make decisions about 
medical care, including preventative care such as vaccines (Javaid et al., 2017). 
Health Belief Model Impact on Vaccine Refusal. 
Krawczyk et al. (2015) conducted a study to identify key differences 
between parents who consented and parents who refused the Gardasil (HPV) 
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vaccine for their daughters.  This study took place in a free vaccination clinic in 
Quebec, Canada, and included a large randomized sample size and return rate.  
Parental surveys were sent and returned via mail.  A total of “834 parents returned 
the questionnaire, and the overall response rate was 33%.  Of those, 774 (92.8%) 
questionnaires had complete data for all relevant items and were included in the 
present quantitative analyses” (Krawczyk et al., 2015, p. 324).  Those surveyed 
were parents of girls who were 9 to 10 years of age.  Of these 774 participating 
parents, 88.2% reported that their daughters received the HPV vaccine.  The 
theoretical framework used for this study was the HBM which was used to 
investigate whether parental beliefs about the Gardasil vaccine guided their 
decision to vaccinate their daughters (Krawczyk et al., 2015).  The study focused 
on how the HBM influenced parental perceptions in their decision to vaccinate 
their daughters and how the knowledge of the Gardasil vaccine guided 
interventions and vaccine programs.  A limitation of this study was that it only 
included parents attending a free vaccine clinic; thus, the results may not be 
applicable to parents of children with insurance (Krawczyk et al., 2015).  
Vaccine Education. 
Lechuga, Swain, and Weinhard (2012) conducted a study to evaluate 
parental decisions to consent to the Gardasil vaccine as a result of the use of the 
Decision Aid (DA).  The DA is a tool that guides parents through their decision to 
vaccinate their children by explaining what the vaccine is/does and addressing 
parental concerns regarding a specific vaccine.  This study was a mixed method 
study using a survey approach which took place within four Health Department 
clinics in Milwaukee, Wisconsin.  The sample group consisted of 150 mothers of 
girls, aged 9 - 17 years, who had not received the vaccine and were receiving WIC 
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assistance from one of four clinics in Milwaukee.  The mothers completed 
questionnaires which focused on intention to vaccinate, emotions toward the 
Gardasil vaccine, the vaccination of boys, and the use of a DA.  The 
questionnaires also assessed ethnicity, age, years of education, insurance, and 
employment status.  The researchers “conducted a content analysis to investigate 
emergent themes in answers to the open-ended item assessing vaccination related 
concerns” (Lechuga, Swain, & Weinhard, 2012, p. 217).  A chi-square analysis, 
ANOVA, was used to analyze quantitative data.  Results showed that, overall, 
mothers benefitted from a DA to assist them in understanding the purpose of the 
Gardasil vaccine. With regard to ethnic groups, African American mothers found 
the decision aid useful in their decision-making process.  Hispanic mothers 
verbalized benefiting from hearing other parents’ experience with the Gardasil 
vaccine.  This study also found the need for physician guidance in parental vaccine 
compliance.  In this study, there was a low parental (mother) concern regarding 
the vaccine’s initiation of early sexual behavior in their children, these results 
were “3% of Hispanics, 6% of African American, and 7% of non-Hispanic White” 
(Lechuga et al., 2012, p. 219).  A strength of the study was that data were 
collected from four health departments.  In addition, the study was able to evaluate 
various ethnic groups; this may help providers focus on specific parental views of 
the vaccine.  A limitation of this study is that the sample group only included 
mothers of girls who did not receive a vaccine; no mothers of boys were surveyed.  
This study could be changed to include mothers of all adolescents—both boys and 
girls—to further look at parental consent or refusal to vaccinate (Lechuga et al., 
2012).  
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Impact of Parent and Provider Communication. 
Rahman, Laz, McGrath, and Berenson (2015) evaluated the association 
between parental HPV awareness and Gardasil vaccine initiation/completion rates 
in adolescent children 13 to 17 years of age (p. 371).  The study examined whether 
or not communication with a provider impacted parents’ decisions to administer 
the Gardasil vaccine to their adolescent children.  The researchers used cross-
sectional surveys already completed via the CDC which were national 
immunization surveys of teens aged 13 - 17 years.  Statistical data were analyzed 
using STATA 12 svy command and logistic regression models to examine the 
independent variable and dependent variable.  The sample size was large: 11,236 
adolescent girls and 12,328 adolescent boys.  Overall, the study noted the 
importance of including provider recommendation of vaccine programs in the 
United States to increase Gardasil vaccine administration.  A strength in this study 
was its use of data from a reliable source, the CDC.  A limitation in this study was 
its lack of examples (such as program websites, parental teaching handouts, or 
vaccine education tools) of how providers might improve communication with 
their patients and their parents to increase Gardasil vaccine success rates (Rahman, 
Laz, McGrath, & Berenson, 2015). 
Brown, Gabra and Pellman (2017) examined reasons for parents’ 
acceptance or refusal of the HPV vaccine in a pediatric practice.  The study was 
conducted over a period of one year, using parental surveys and evaluating the 
reasons for agreeing or refusing initial HPV vaccination following a practitioner 
recommendation (Brown, Gabra, & Pellman, 2017, p. 42).  Parents were surveyed 
after their children’s doctor appointments at which HPV vaccine education was 
provided by the provider.  A total of 200 parents participated in surveys, 
answering questions about demographics and reasons for accepting or refusing the 
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vaccine.  In evaluating the data collected, “a univariate descriptive statistic was 
used to examine age, gender, familial/friend diagnosis, and reasons for or against 
vaccination” (Brown, et al., 2017, p. 43).  The study revealed that the physicians’ 
recommendation was the major factor (84.1%) in parents’ decisions to administer 
the HPV vaccine to their children (Brown et al., 2017).  The most common reason 
identified for vaccine refusal was the need for further research (Brown et al., 2017, 
p. 43).  The survey’s small sample size was considered a limitation to the study. 
Overall, the researchers found that physician recommendation for HPV vaccine 
influenced parental decision in accepting the vaccine for their child. 
Teaching Tool Evaluation. 
Cipriano, Scoloveno, and Kelly (2018) also examined parental attitudes and 
consent or refusal of the HPV vaccine by evaluating a parental intervention 
focused on increasing parental knowledge of the HPV vaccine.  The study took 
place in a pediatric clinic in the state of New Jersey, using a pre- and post-
intervention design.  The researchers used a computer-based training module in 
which parents were given the HPV vaccine education and then were given post 
surveys.  A limitation noted by the researchers was the possibility of parental 
misunderstanding of the vaccine information that was given to Spanish-speaking 
parents on the digital tablet they were provided.  The researchers concluded that 
the main reasons for parental refusal for the HPV vaccine was a lack of 
understanding regarding the HPV vaccine and children were not sexually active at 
the time of the administration of the vaccine.  Overall, the study focused on 
increasing parental comprehension of the HPV vaccine, and the results indicated 
that there was an increase in knowledge. 
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Summary 
An examination of past research studies which focused on parental refusal 
of the HPV vaccine highlighted gaps regarding provider/parental communication, 
vaccine education, and parental comfort with vaccine side effects.  Therefore, it is 
necessary for advance practice nurses to address parental feelings about the HPV 
vaccine, for this may positively influence patient health outcomes.  If such 
intervention is implemented in the healthcare system, advance practice nurses will 
have the opportunity, through consultations, to build trusting relationships with 
parents.  The following chapter outlines the HPV vaccine program in which 
vaccine refusal, vaccine education, and parental/provider rapport are evaluated. 
 
   
CHAPTER 3: METHODOLOGY 
Project Design 
In this study, a qualitative content analysis was conducted to evaluate the 
reasons for parental refusal of the HPV vaccine.  The purpose of this study was to 
interview 10 - 12 parents who had refused the HPV vaccine for their adolescent 
children and determine the reasons for this refusal.  Through this study, the 
researcher provided each parent with a teaching session followed by a follow-up 
interview over the phone one month later to assess outcomes and determine if the 
teaching session had changed parental decisions to refuse the vaccine. 
Program Setting 
The HPV vaccine program and interviews took place at Dr. Javier Amu 
Professional Corporation, a rural pediatric healthcare clinic located in Reedley, 
California.  Interviews with parents were conducted by this researcher in a 
conference room at this clinic.  Additionally, phone call assessments were 
conducted using the confidential phone in the clinic office.  
Sample Population 
The subject population included parents who had refused the HPV vaccine 
for their adolescent children and who received primary care in the rural health 
clinic. 
Recruitment of Participants 
The study subjects consisted of parents who obtained pediatric patient care 
services for their adolescent children in this pediatric rural healthcare clinic.  The 
researcher obtained Institutional Review Board (IRB) approval from the California 
State University, Fresno, and from Dr. Amu, the pediatrician/owner of the rural 
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health clinic, prior to beginning the research study and parental interviews (see 
Appendices F and G).  
Sampling Procedures 
Participants for the interviews and the phone call assessments were 
collected through the clinic’s electronic medical record, PRAXIS.  Adolescent 
patients who were delinquent with any of the HPV vaccine doses were identified, 
and parental information was obtained.  The researcher contacted each 
parent/participant and asked for voluntary participation in interview and phone call 
assessment for this vaccine program.  After parents agreed to participate in this 
study, informed consents which explained the research study program were 
obtained, and the researcher then initiated interviews (see Appendix H). 
Ethical Considerations 
Risk from ethical problems in this study was minimal, for informed consent 
was obtained from parents (study subjects) prior to in-person interviews and 
phone-call assessments.  This study was approved by the IRB at California State 
University, Fresno. 
Measures 
Using a qualitative research design by means of semi-structured face-to-
face interviews, the researcher identified and evaluated reasons for parental HPV 
vaccine refusal.  After implementing a parental teaching session, follow-up phone 
call assessments took place one month later to evaluate parental decisions to 
accept or refuse the HPV vaccine.  
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Research Design 
Data Collection Methods 
The parental interview addressed the four survey questions which were 
used as part of Kinder’s (2016) research in evaluating parental refusal of the HPV 
vaccine (see Appendix A).  Permission to use these questions for the purposes of 
this study was obtained from assistant professor at La Salle University, Frances 
DiAnna Kinder, PhD, RN (see Appendix B).  For this project, this researcher 
asked the following questions to assess vaccine refusal:  
1. How many times has the vaccine been offered to you? 
2. Where do you obtain most of your medical information? (Kinder, 2016, 
p. 555). 
3. What was your reason for refusal of HPV vaccine for your child? 
4. What would influence your decision to consent for HPV vaccine easier? 
(See Appendix A). 
As part of the interview, the following demographics were requested: relationship 
to child, educational level of parent, parental age, and patient age and sex (see 
Appendix C).   
The second component of the HPV vaccine program was an educational 
teaching session with parents.  The researcher included all of the recommended 
vaccines in the teaching session such as HPV infection information, HPV vaccine, 
and a vaccine schedule calendar.  A 10-minute educational session was provided 
to each parent which took place in the same session as the interview, using a 
resource tool provided by the CDC, “6 Reasons to Get HPV Vaccine for Your 
Child” (CDC, 2018).  (See Appendix D). The resource tool was provided in the 
parents’ native speaking language (Spanish or English).  If parents had requested 
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information in a different language, the researcher would have provided the 
information as needed, however no other language resources were required. 
The third component to this vaccine program consisted of a follow-up 
phone call assessment conducted by the primary researcher one month after the 
appointment at the health clinic.  Each parent that was interviewed and 
participated in the teaching session received a call.  The questions asked were as 
follows: 
1. Can you remember why you refused HPV vaccine for your child?  
2. What did you learn about the HPV vaccine after the teaching session?  
3. Has your opinion changed about consenting to the vaccine for your 
child? If so, why?   
4. Will you consent for refuse HPV vaccine for your child?  
The primary researcher followed a detailed script while conducting each 
phone call assessment (see Appendix E). 
After the interviews, teaching sessions, and follow-up phone calls took 
place, parental responses were evaluated to determine whether there were any 
specific or common barriers/themes to parental refusal of the HPV vaccine.  A 
content analysis was conducted as an evaluation of the effectiveness of the 
teaching session for parental decision to consent for the HPV vaccine.  As 
previously described, the data analysis method was a qualitative study using semi-
structured interviews with parents who refused the HPV vaccine for their 
adolescent children aged 11 – 17 years.  
Data Analysis 
The content analysis included the data/answers gathered from interviews 
and follow-up phone call assessments which were completed during this vaccine 
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program.  As defined in Melnyk and Fineout-Overholt (2015), content analysis 
involves extracting themes, patterns, processes, essences, and meanings from 
textural data.  Based on these findings, future studies may be implemented, 
addressing parental concerns and reasons for the refusal of the HPV vaccine. 
Summary 
Parent interviews and phone-call assessment answers were evaluated and 
identified in relation to barriers to HPV vaccine acceptance and reasons for HPV 
vaccine refusal.  This vaccine program also focused on parental/provider 
education and analyzed its influence on parental acceptance or refusal of the HPV 
vaccine.  Results of this study will provide further vaccine program interventions, 
education tools, and parental support for increasing parental vaccine compliance.  
In the following chapter, there is a content analysis discussion on the results of the 
HPV vaccine study. 
 
 
   
CHAPTER 4: RESULTS 
This chapter summarizes this vaccine program’s in-person interviews, 
follow-up phone-call assessments, and patient and parent demographics.  The 
qualitative research study design includes the content analysis conducted with data 
collected during the vaccine program.  
Sample Characteristics 
This study included 13 parents who participated in the vaccine program, 
including in-person interviews, teaching sessions, and phone-call assessments. 
Table 1 shows the demographic information of the 13 parents who participated in 
the study.  The interviewed participants included a total of two fathers and 11 
mothers.  Parental age groups varied from 31 to 52 years of age.  Parents’ 
education levels varied from a completion of the sixth grade to a college 
bachelor’s degree.  Ethnicity also varied: there was one White father, one Native 
American mother, one Hispanic American mother, and 10 Hispanic parents who 
participated in the study.  The sex and age of the participants’ children were also 
identified as part of the demographic information for the study.  Seven parents had 
female children (54%), while six parents had male children (46%).  The children’s 
ages varied from 11 to 14 years. 
In-person Interviews Data Analysis 
Qualitative  
A total of 13 in-person parental interviews were conducted by the 
researcher and took place in the conference room of the clinic.  The following 
section reviews the data collected during the interviews which used four open-
ended questions.  The first interview question asked about the amount of times the 
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HPV vaccine had been offered to the parents.  One parent stated, “The vaccine has 
never been offered to me” (8%).  Six parents (46%) verbalized that the vaccine 
had been offered once.  There were two parents (15%) who said the vaccine was 
offered twice.  Three parents (23%) claimed that the vaccine was offered three 
times.  One parent (8%) stated the vaccine was offered multiple times.  
Table 1. Demographic Characteristics of the Participants (N=13) 
Characteristic Percentage 
Relationship to patient  
Mother 
Father 
Parental age  
31-40 
41-48 
>49 
Parental education level  
Sixth grade 
Junior High School 
High School 
Some college – Bachelor’s 
Parent Ethnicity  
White  
Hispanic 
Native American  
Patient sex  
Male 
Female 
Patient age  
11-12 
13-14 
 
84.6 
15.4 
 
46.2 
23.1 
30.7 
 
15.4 
7.7 
38.5 
38.5 
 
7.7 
84.6 
7.7 
 
46.2 
53.8 
 
61.5 
38.5 
The second question of the interview asked parents where they obtained 
their medical information, and answers included the internet, clinic, medical 
providers, and research articles.  A couple of parents stated that they obtained 
medical information from multiple sources.  A total of nine parents (69%) 
obtained their information from the medical clinic or doctor.  There were eight 
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parents who stated they received their medical information from websites (61%).  
Three parents (23%) obtained their information from research-based articles/data.  
Reasons for Parental Vaccine 
Refusal 
Lack of information or vaccine education. Interview data for questions 
three and four are discussed using themes in qualitative content analysis.  The 
third assessment question addressed the reasons for parental refusal of the HPV 
vaccine.  The largest theme/reason verbalized by parents for their refusal of the 
vaccine was the lack of education or information provided regarding the purpose 
for the HPV vaccine.  Parents verbalized not “knowing and understanding” the 
HPV virus and how the vaccine prevented cervical cancer and genital warts.  In 
reviewing these data, a common theme for parental refusal of the HPV vaccine, as 
verbalized by many parents, was their fear of the vaccine’s side effects.   
Vaccine side effects. During the interviews, a frequent concern and reason 
for refusal that was voiced by many parents was the side effects of the vaccine.  
Whether the parents misunderstood the side effects or read about the side effects 
online, it was clear that these views impacted parents’ decisions to refuse the 
vaccine for their children.  One parent stated, “I read a story online in which a 
young lady received the HPV vaccine and went into a vegetative state.”  Another 
mother stated that she had refused the HPV vaccine because she was “worried 
[her] daughter could have a reaction to the vaccine.”  To address parental concerns 
about side effects, there is a Vaccine Information Sheet (VIS) that is provided 
during patients’ physical exam at recommended age that identifies the possible 
side effects of the HPV vaccine.   
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Young age of patient at the time of HPV vaccination.  During the 
parental interviews, three out of the 13 parents expressed their concern about their 
children being “too young” to worry about the HPV virus.  One father stated he 
felt that the “HPV vaccine would give [his] daughter a false sense of protection 
against sexually transmitted viruses.”  This father continued to discuss why he felt 
his daughter, at her young age, was unable to understand the purpose of the HPV 
vaccine or the significance of the HPV virus.  These three parents questioned why 
the vaccine was necessary at this stage when their child would not be exposed to 
the virus.  The recommended age for the HPV vaccine is between 9 and 11 years 
of age, and in this rural health clinic, it was recommended at 11 years old.  
Because of their concerns about the young age of the children, parents’ hesitancy 
about discussing the HPV virus with their children and how the virus is 
transmitted sexually was a large part of parental vaccine refusal.  
Underlying illness or medical concern.  Another common reason for 
vaccine refusal was postponing physical exams due to children’s underlying 
medical history, whether these were acute or chronic.  For example, illnesses such 
as type 1 diabetes, cold symptoms, or hives/allergy symptoms were commonly 
used as reasons for postponing the vaccination.  Parents of children with such 
conditions expressed concerns about how their children would react to the HPV 
vaccine because of their underlying illnesses.  In addition, common reasons for 
vaccine refusal or missed doses included being unaware of a required second dose, 
missing physical exams, or not scheduling exams.  One mother stated, “I was not 
told about the vaccine dose schedule during my son’s physical exam.”  Non-
compliance for completing the vaccine series, misinformation regarding the 
purpose of the HPV vaccine, and lack of knowledge regarding the vaccine 
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schedule were common concerns in both the literature reviewed for this study and 
within this study’s parental interview responses. 
Decision to Consent 
Vaccine education. The final open-ended question of the in-person 
interview was intended to determine what might support parental decisions to 
consent to the HPV vaccine.  The most common answer to this question was the 
need for more vaccine education.  Parents verbalized the need for clarification 
regarding vaccine purpose, side effects, and the vaccine schedule.  One father 
stated, “I need to see more data, statistics, and opposing data in regard to the HPV 
vaccine.”  Another father wanted to know more about the vaccine’s benefits: “I 
want to know more about the studies and research about how the HPV vaccine 
works.”  One mother wanted to hear more about how the vaccine could prevent 
future medical problems for her child.  Understanding the pros and cons of the 
HPV vaccine was a clear theme noted as a result of this open-ended question.   
Vaccine schedule reminders. The second common theme indicated by the 
data was the need for more reminders and clarification of the vaccine schedule.  
Providing vaccine series education to parents could support their decision to 
consent to the HPV vaccine and comply with vaccine doses.  As parents continued 
to discuss the need for further detailed information on the HPV vaccine schedule, 
many mentioned how they felt as if frequent reminders and communication with 
the clinic providers and staff could increase vaccine compliance, and as a result, 
parents would be more likely to consent to vaccinate their child. 
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Phone-Call Assessment Data 
Vaccine side effects.  A phone-call assessment which consisted of four 
questions was conducted with each parent one month after the personal interviews.  
There was a total of 12 parents who participated in the phone call assessments 
(92%).  The first assessment question asked if parents recalled their reason for 
refusing the HPV vaccine for their children.  Once again, the leading reason 
parents indicated for their refusal of the vaccine was concerns about the possible 
side effects of the vaccine.  One mother was concerned about possible 
neurological side effects, such as autism or other developmental issues; other 
parents feared unknown side effects that perhaps have not been found or shared 
with the general public.  One mother stated a concern that her daughter might 
possibly have “an allergic reaction because the HPV vaccine would be a new 
vaccine for her.”  As indicated in the literature, parents may require more 
information on the vaccine’s actual side effects, for these real-life examples may 
decrease parental refusal of the HPV vaccine. 
HPV virus sexual connectivity.  A common theme noted in the literature 
reviewed for this study regarding parental refusal to the HPV vaccine was its 
connectivity to sexual behavior or sexually transmitted diseases.  This notion was 
also present in the data from this study.  One father stated that he refused the 
vaccine because he was “worried about giving [his] daughter the false illusion of 
protection against sexually transmitted diseases.”  In this case, health care provider 
education could have impacted the father’s understanding of the HPV virus, HPV 
related diseases, and overall purpose of the vaccine.  Evaluating parental 
knowledge of the HPV virus may create parental/provider rapport and create a 
clearer parental understanding of the significance of the vaccine for children.  
 27 27 
Lastly, this program’s first follow-up question indicated that the need for further 
education and a lack of parental understanding of the vaccine played a large part in 
parental refusal of the vaccine.  If medical providers cannot clarify the reasons for 
vaccine refusal, such refusal cannot be addressed, compliance cannot be achieved, 
and preventative health cannot be prioritized. 
Teaching Session Lessons 
Question number two of the follow-up assessment asked parents to discuss 
what they had learned from the teaching session that was conducted by the 
researcher following their interviews; overall, parents expressed that, as a result of 
the session, they had gained a clearer understanding of the diseases caused by the 
HPV virus.  One mother specifically stated that she “learned about the benefits of 
the vaccine regarding cervical cancer and other cancers that [she] was not aware 
could be a concern.”  Another mother indicated that, because of the teaching 
session, she had learned “how beneficial the vaccine was.”   
Parental Opinion to Consent 
Understanding the vaccine to consent or refuse.  When parents were 
asked during the follow-up assessment whether or not they had changed their 
opinion about consenting to the HPV vaccine, many parents took the opportunity 
to further discuss the vaccine.  While assessing parents who had consented to give 
the HPV vaccine to their children, this researcher noticed that such parents wanted 
to discuss their feelings in more detail; this allowed for the parents to once again 
verbalize their understanding and decision to give their child the HPV vaccine, 
discuss the importance of the vaccine, and ask more questions about the HPV 
vaccine.  Out of the 12 parents who participated in the follow-up assessments, one 
 28 28 
parent said she would continue to think about her decision to vaccinate her child.  
There was a total of seven parents (58%) who decided to consent to the HPV 
vaccine.  During the phone call assessment, one mother stated, “I now understand 
the importance of this HPV vaccine for my son.” Four parents (33%) continued to 
refuse the HPV vaccine for their children.  All parents stated that they understood 
the HPV vaccine’s purpose after participating in the teaching session with the 
researcher.   
Parental Consent or Refusal of the 
HPV Vaccine 
The final question of the phone assessment focused on the decision of the 
parent to consent or refuse the administration of the HPV vaccine.  After 
participating in the interview, teaching session, and phone call assessment, parents 
were asked if their decision had changed.  Four parents continued to refuse the 
vaccine for their children; all three parents had daughters.  One parent was unable 
to make a decision to consent for her daughter at that time and stated that she 
wanted “more time to think about the vaccine and its purpose for her daughter.”  A 
total of seven parents decided to change their decision to refuse the vaccine and 
consented to the administration of the HPV vaccine to their children.  Figure 1 
demonstrates the parental decisions to consent or to continue to refuse the HPV 
vaccine for their children. 
As seen by the results in Figure 1, this study’s vaccine program positively 
impacted parental decisions regarding the HVP vaccine by encouraging seven 
parents (58 %) to change their decision and consent to the vaccine.  In the 
following chapter, the strengths, limitations, and nursing implications of this HPV 
vaccine program study are analyzed. 
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Figure 1. Chart depicting HPV vaccine parental consent or refusal. 
 
 
   
CHAPTER 5: DISCUSSION 
The goal of this HPV vaccine program/study was to identify and evaluate 
the reasons for parental refusal of the HPV vaccine in a rural healthcare clinic 
setting.  In the literature reviewed, there were various methods for identifying 
parental vaccine refusal.  This study and vaccine program focused on open-ended 
in-person interviews, parental vaccine teaching sessions, and a one-month follow-
up assessment which evaluated the parents’ change in consenting to the HPV 
vaccine for their children. 
Project Outcomes 
The primary outcome for this HPV vaccine program was the identification 
of reasons for parental refusal to the HPV vaccine.  The in-person interview 
questions served as a mode of communication between the researcher and parents.  
During the interviews, parents were able to answer each question regarding the 
HPV vaccine and their reasons for refusing the vaccine for their children.  The 
second outcome was the use of the teaching session or educational tool which 
helped increase parental knowledge of the HPV vaccine.  Finally, the follow-up 
phone-call assessments conducted one month after parent interviews were used to 
evaluate the interviews and teaching sessions’ impact on changing parental refusal 
of the HPV vaccine.  Overall, this study increased parental understanding of the 
HPV vaccine, including the vaccine’s purpose and preventative measures.  This 
study/vaccine program resulted in several parents’ changing their decision from 
refusing the HPV vaccine to consenting to the administration of the HPV vaccine 
for their children. 
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Nursing Implications 
As noted in the literature review provided in this study, parents and 
caregivers need more information about the HPV vaccine.  Some studies evaluated 
the use of a decision aid or someone who could further explain the HPV vaccine 
after a medical provider recommended the vaccine.  Cipriano et al. (2018) used a 
self-directed, computer-based learning tablet application which helped teach 
parents about HPV vaccine. Various parents within this study’s interview process 
also indicated that more information regarding how the HPV vaccine works could 
impact their decision to consent to the vaccine.  Parental resistance or fear to 
consenting to the HPV vaccine for their children may decrease with a health care 
provider’s emphasis on vaccine education and explanation of HPV related 
diseases.  Clarifying the HPV virus risks, vaccine research, and children’s future 
risks may impact the parental decision to consent to the vaccine.  
Parental vaccine education. Application of this vaccine program’s 
findings may help those in the medical profession to identify parental education 
focus points and may decrease parental fears and resistance to the HPV vaccine 
for their children.  A study conducted by Brown et al. (2017) revealed that a 
deciding factor for parental refusal was the feeling that their children were not old 
enough for the vaccine (p. 43).  As discussed in Chapter 4, during the parental 
interviews for this study, parents also expressed that their children’s age/young 
age was a factor in refusing to administer the HPV vaccine at the recommended 
time.  The interviews and assessment results of this study revealed a change in 
parental decisions to consent to the HPV vaccine after attending the teaching 
session provided by this study’s vaccine program.  Thus, stressing the possible 
future implications of the HPV virus exposure to parents is an important aspect of 
HPV vaccine education. 
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Recommended age and sexual behavior. Parental concerns of sexual 
behavior or connectivity of sexual activity associated with the HPV vaccine was 
also a common theme in both this study and the literature.  One study discussed 
the parental worry about the HPV vaccine’s being related to sexual intercourse and 
behaviors; this concern was a primary factor in many parents’ decision to refuse 
the vaccine for their children (Fleming et al., 2018).  Multiple studies confirmed 
the common reason for parental refusal of the HPV vaccine stemmed from the 
early age at which the vaccine was given: many felt the vaccine was given too 
early, for children were not sexually active at the time.  In this study, some parents 
did not feel comfortable with administering the vaccine, believing it was 
connected to a virus which was sexually transmitted. 
Teaching intervention. This researcher was able to conduct parental 
teaching sessions which increased parental vaccine understanding.  Healthcare 
providers such as nurse practitioners may continue to focus on health promotion 
and preventative healthcare, such as vaccine education and parental teaching 
support.  During this vaccine program, the teaching sessions created opportunities 
for parents to not only learn about the HPV vaccine but to also reevaluate their 
decision to vaccinate their children.  The positive impact of the vaccine education 
session was noted in the follow-up assessments, as seven parents (58%) changed 
their decisions to consent to and administer the vaccine to their children. 
Vaccine schedule and compliance. Understanding the HPV vaccine 
schedule and doses can improve patients’ vaccine series compliance.  As stated by 
various parents during the in-person interviews, the lack of reminders on the HPV 
vaccine series doses and scheduling their follow-up appointments impacted their 
decision to refuse or complete the HPV vaccine doses.  One parent asked about the 
vaccine schedule and how the vaccine schedule was reinforced in the rural 
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healthcare clinic.  Vaccine schedule reminders may vary, and in this study, there 
were some parents who were unaware of there being a second HPV vaccine dose. 
Healthcare providers such as nurse practitioners may impact vaccine series 
compliance by creating better vaccine appointment protocols and reminders in 
outpatient rural pediatric clinics. 
Strengths 
One strength of this study’s HPV vaccine program is that the vaccine 
program provided an educational tool: the teaching session increased parents’ 
understanding of the HPV vaccine and influenced their decision to vaccinate their 
children.  Another strength of this study was the ability of the researcher to 
provide the interview questions, teaching session, and phone call assessments in 
the parents’ native language: Spanish or English. Additionally, this study was the 
only one in this researcher’s knowledge which used in-person interviews followed 
by parental teaching sessions and a one-month follow-up phone assessment which 
evaluated the reasons for parental consent to or refusal of the HPV vaccine.  The 
last strength of this study was the positive impact which the study had on changing 
parental decisions to consent to the HPV vaccine for their children. 
Limitations 
A limitation to this study was the program’s focus on only one specific 
patient and parent population in a rural healthcare clinic.  Future studies may be 
conducted in larger pediatric and family practice clinical health settings, 
increasing research data findings.  This vaccine program was limited to the parents 
whose children received their primary care at the identified rural healthcare clinic.  
Another limitation noted in the study was the inability of the researcher to contact 
one parent to complete this parent’s follow-up phone call assessment.  
 34 34 
Recommendations for Further Studies 
This HPV vaccine program focused on one vaccine, the HPV vaccine, 
which is often refused by parents in the rural healthcare clinic setting.  Notable in 
the results of the one-month follow-up assessments was the fact that parents 
learned about the HPV vaccine individually; this positively impacted their 
decision to consent to the vaccine. Further research studies may focus on other 
recommended pediatric vaccines also refused by parents.  Future vaccine 
programs may follow this study’s methodology, using in-person interviews, parent 
teaching sessions, and one-month follow-up assessments to increase consent to 
other vaccines that are often refused.  The goals of such vaccine programs should 
be as those provided in this study: to address, identify, and evaluate the reasons for 
parents’ refusal of these vaccines.  
In conducting this study, this researcher found a gap in parental 
understanding of the purpose for and schedule of the HPV vaccine.  Focusing on 
increasing parental vaccine education—whether it incorporates more vaccine 
handouts, longer teaching sessions with parents, or introducing vaccine programs 
within clinical settings—healthcare providers such as nurse practitioners may 
positively impact vaccine education and vaccine series compliance. 
Future vaccine programs such as this study may impact clinical vaccine 
protocols and promote positive patient care outcomes within pediatric and family 
practice settings.  For healthcare providers and nurse practitioners, the focus on 
health promotion and preventative health measures such as vaccines are a large 
part of pediatric patient care.  While conducting this vaccine program, the 
researcher was able to create a learning environment for parents, conduct vaccine 
education, and re-evaluate the parental decision to administer the HPV vaccine to 
their children.  This vaccine program may be used to promote parental knowledge 
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of the HPV vaccine and other vaccines and to impact vaccine series compliance 
rates for pediatric and adolescent patients. 
Conclusion 
This vaccine study identified the reasons for parental refusal of the HPV 
vaccine in a pediatric rural health clinic.  The vaccine program’s findings noted 
the influence of teaching sessions in changing parents’ decisions to consent to the 
HPV vaccine for their children.  Preventative services such as vaccines, 
specifically with the HPV vaccine which prevents diseases caused by the HPV 
virus, may be impacted by successfully administering all the doses within the 
vaccine series.  Healthcare providers, such as nurse practitioners who care for 
pediatric patients, should continue to focus on communicating with their patients’ 
parents by using vaccine programs such as this one to create a positive impact on 
their patients’ health. 
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Kinder Survey Vaccine Refusal Questions 
1. How many times has the vaccine been offered to you? 
2. Where do you obtain most of your medical information? 
3. What was your reason for refusal of HPV vaccine for your child? 
4. What would influence your decision to consent for HPV vaccine easier? 
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Permission to Use Kinder Survey Questions 
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Demographic Form 
1. Relationship to patient 
2. Educational level 
3. Parent age 
4. Parent ethnicity 
5. Patient sex 
6. Patient gender 
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6 Reasons to Get HPV Vaccine for Your Child 
 
 
   
APPENDIX E: SCRIPT FOR PHONE CALL ASSESSMENT 
 50 50 
Script for Phone Call Assessment 
Hello, my name is Magdalena Ruiz, I am the nurse practitioner and primary 
investigator who conducted your face-to-face interview and teaching session that 
took place one month ago at Dr. Amu’s pediatric clinic. First, thank you for your 
time and willingness to participate in this HPV vaccine research study. I will now 
be asking you four questions as part of the study: 
1. Can you remember why you refused HPV vaccine for your child? 
2. What did you learn about the HPV vaccine after teaching session? 
3. Has your opinion changed about consenting vaccine for your child? If 
so why? 
4. Will you consent or refuse HPV vaccine for your child?   
Thank you so much for your time and participation in this vaccine study. If 
you have any future questions about research, please feel free to contact me at 
559-743-7340. 
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